Precise Therapeutic Benefits and Underlying Mechanisms of Anlotinib Combined With Checkpoint Immunotherapy in Advanced Non-Small-Cell Lung Cancer.
Xiang Y, Lu XJ, Sun YH, Liu X, Wu YY, Rao H, Que QY, Xiao Q, Zhu R, Feng XF, Lai WL, Zou XH, Wang Y, Qiu S, Huang L, Shi HQ, Wang XC.
Xiang Y, et al. Among authors: que qy.
World J Oncol. 2022 Oct;13(5):320-324. doi: 10.14740/wjon1494. Epub 2022 Oct 22.
World J Oncol. 2022.
PMID: 36406194
Free PMC article.
No abstract available.